Angiotensin Ii Receptor Blocker (arb) - Neonatal Disorders

Relevant Publications

Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study data.

Issue Release: 2024

From Hypertension to Beyond: Unraveling the Diverse Mechanisms of Olmesartan in Disease Modulation.

Issue Release: 2024

Conversion of Olmesartan to Olmesartan Medoxomil, A Prodrug that Improves Intestinal Absorption, Confers Substrate Recognition by OATP2B1.

Issue Release: 2024

Are Guideline Concordant Processes of Care Consistent Across the Rural-Urban Continuum? A Retrospective Cohort Study of Adults Newly Treated for Type 2 Diabetes.

Issue Release: 2024

Systematic Review Examining the Association of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Prescription with Abdominal Aortic Aneurysm Growth and Events.

Issue Release: 2024

Efficacy and safety of dual renin-angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR.

Issue Release: 2024

Assessing Discharge Communication and Follow-up of Acute Kidney Injury in British Columbia: A Retrospective Chart Review.

Issue Release: 2024

Advancing Community Care and Access to Follow-up After Acute Kidney Injury Hospitalization: Design of the AFTER AKI Randomized Controlled Trial.

Issue Release: 2024

Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study.

Issue Release: 2024

Idiopathic nodular glomerulosclerosis: A case report and literature review.

Issue Release: 2024

Effect of angiotensin-converting enzyme inhibitors that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study.

Issue Release: 2024

Losartan and metabolite EXP3179 activate endothelial function without lowering blood pressure in AT2 receptor KO mice.

Issue Release: 2024

Sacubitril-valsartan vs ACE/ARB in pediatric heart failure: A retrospective cohort study.

Issue Release: 2024

Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging.

Issue Release: 2024

A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals.

Issue Release: 2024

Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome.

Issue Release: 2024

ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.

Issue Release: 2024

Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors in acute myocardial infarction without heart failure.

Issue Release: 2024

Effects of Cardioprotective Drugs on 90-Day Mortality or Heart Transplantation in Patients With Fulminant Myocarditis.

Issue Release: 2024

Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction.

Issue Release: 2023

What Are the Future Directions in Neonatal Therapies?

What is Gestational Diabetes?

Why is "Back to Sleep" Important?

What is a Pediatric Insurance Contract?

What is Unstructured Play?

What is Antisocial Personality Disorder (ASPD)?

When Can Children Start Eating Cruciferous Vegetables?

What is Data Protection in Pediatrics?

What are Biodegradable Diapers?

What is Under Coding in Pediatrics?

Angiotensin Ii Receptor Blocker (arb) - Neonatal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics